BioMed Research International

BioMed Research International / 2021 / Article

Research Article | Open Access

Volume 2021 |Article ID 6621027 | https://doi.org/10.1155/2021/6621027

Jung Eun Kim, Hye Ran Kim, Jin Cheol Kim, Eun Soo Lee, Choon Hee Chung, Eun Young Lee, Bo Young Chung, "Tetrahydrocurcumin Ameliorates Skin Inflammation by Modulating Autophagy in High-Fat Diet-Induced Obese Mice", BioMed Research International, vol. 2021, Article ID 6621027, 8 pages, 2021. https://doi.org/10.1155/2021/6621027

Tetrahydrocurcumin Ameliorates Skin Inflammation by Modulating Autophagy in High-Fat Diet-Induced Obese Mice

Academic Editor: Maxim E. Darvin
Received26 Nov 2020
Accepted29 May 2021
Published15 Jun 2021

Abstract

Obesity can induce chronic low-grade inflammation via oxidative stress. Tetrahydrocurcumin (THC) is a major curcumin metabolite with anti-inflammatory and antioxidant effects, but little is known about its effects on the skin of obese individuals. Thus, the aim of this study was to investigate the effects of THC on inflammatory cytokine production, oxidative stress, and autophagy in the skin of mice with high-fat diet- (HFD-) induced obesity. Eight-week-old C57BL/6J mice were fed a regular diet, HFD (60% of total calories from fat), or HFD supplemented with THC (100 mg/kg/day orally) for 12 weeks. We measured their body weights during the experimental period. After 12-week treatments, we performed western blotting and real-time polymerase chain reaction analyses on skin samples to evaluate the expression of inflammatory cytokines, oxidative stress markers, and autophagy markers. We observed higher tumor necrosis factor-α (TNF-α), NADPH oxidase 2 (Nox2), Nox4, and phosphorylated p65 levels; lower nuclear factor erythroid 2-related factor 2 (Nrf2) expression; and higher light chain 3 (LC3), autophagy-related 5 (Atg5), and Beclin 1 expression in the skin of HFD mice compared to the corresponding levels in the skin of mice fed with regular diet. THC administration decreased TNF-α, Nox2, Nox4, and phosphorylated p65 levels and activated the Nrf2 pathway. Interestingly, THC administration suppressed the expression of the autophagy markers LC3, Atg5, and Beclin 1. Overall, HFD-fed mice exhibited an elevation in inflammation, oxidative stress, and autophagy in their skin. THC ameliorated obesity-related skin pathology, and therefore, it is a potential therapeutic agent for obesity-related inflammatory skin diseases.

1. Introduction

Obesity, a global health problem, is a major cause of systemic metabolic inflammation and various diseases, including type 2 diabetes, dyslipidemia, hypertension, and cardiovascular diseases [1]. Obesity has also been linked to various skin conditions, such as lymphedema, acanthosis nigricans, striae distensae, and psoriasis [24]. Obese individuals often experience reduced skin barrier function, dry skin, and itching [5]. However, the mechanisms underlying obesity-associated skin pathologies remain unclear.

Autophagy is the primary process involved in the cellular elimination of toxic protein aggregates, damaged organelles, and invading microorganisms [6]. By degrading signaling components, autophagy can regulate the NF-κB signaling pathway and affect immune responses [7]. Autophagy plays an important protective function against obesity and obesity-induced lipotoxic, proteotoxic, and oxidative stresses and thereby preserves physiological homeostasis in the human body [8]. However, obesity and its associated stresses can disrupt the autophagic process, further exacerbating obesity-related abnormalities in multiple metabolic organs [9, 10]. Autophagy is also implicated in multiple skin disorders such as infectious skin disease, psoriasis, and skin cancer [1114]. However, to the best of our knowledge, there has been no study on the effects of obesity-induced skin pathologies on autophagy.

Curcumin (1,7-bis[4-hydroxy-3-methoxyphenyl]-1,6-heptadiene-3,5-dione) is an active component in turmeric rhizomes (Curcuma longa Linn.), a common spice in dishes such as curries. Curcumin has antioxidative, anti-inflammatory, antihyperlipidemic, hypoglycemic, and anticarcinogenic properties [15]. It also has protective effects against diabetes mellitus-related nephropathy, retinopathy, and vascular diseases [16]. Tetrahydrocurcumin (THC) is a reduced curcumin analog found in the gastrointestinal tract; it has a stronger antioxidant activity than curcumin [17].

Here, we aimed to determine the molecular events driving diet-induced obesity-related inflammation, oxidative stress, and autophagy in the skin. Furthermore, we examined the effects of THC on skin, including autophagy, in a diet-induced obese mouse model.

2. Materials and Methods

2.1. Animal Experiments

All animal procedures were approved by the Institutional Animal Care and Use Committees of Yonsei University, Wonju, Korea (YWC-170802-2). Six-week-old male C57BL/6J mice (15 g) were purchased from Dae Han Link (Chungbuk, Korea). The mice were housed in animal rooms at a constant temperature of and a 12 h light/dark cycle. After a 2-week acclimatization period, the 8-week-old C57BL/6J mice were assigned to the following three groups: regular diet (), high-fat diet (HFD, ), and HFD orally supplemented with 100 mg/kg/day THC (Sigma-Aldrich, St. Louis, MO, USA (96.5% purity, Figure 1)) (HFD+T100, ). HFD provided 60% of energy in the form of fat (D12492; Research Diets, New Brunswick, NJ). 94% of fatty acids in the HFD was composed of palmitic acid (20%), stearic acid (11%), oleic acid (34%), and linoleic acid (29%). THC was provided in the mouse chow. During the 12-week experimental period, we monitored the changes in food intake and body weight of the mice on a weekly basis. At the end of the experiment, we euthanized the mice and immediately excised the shaved skin.

2.2. Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR)

Total RNA was extracted using the RNeasy® Plus Mini Kit (Qiagen, Hilden, Germany). We used the Transcriptor First-Strand cDNA Synthesis Kit (Roche Applied Science, Mannheim, Germany) to synthesize cDNA from the total RNA (1 μg). We performed qPCR in triplicate using the TaqMan™ Master Mix and Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). We used the primers of LC3 (also known as Map1lc3a; TaqMan Assay ID Mm00458724_m1), Atg5 (Mm001187303_m1), Becn1 (Mm01265461_m1), p65 (also known as Rela; Mm01310735_m1), Nox2 (Mm01287743_m1), Nox4 (Mm00479246_m1), Nrf2 (Mm00477784_m1), and TNF-α (Mm00443258_m1) in this study. We normalized the mRNA levels of LC3, Atg5, Becn1, p65, Nox2, Nox4, Nrf2, and TNF-α to that of GAPDH (Mm02758991_m1). Relative quantification was performed using a LightCycler® 96 Instrument (Roche Diagnostics, Mannheim, Germany).

2.3. Western Blotting

The mouse skin tissues were extracted in PRO-PREP™ lysis buffer (Intron, Seoul, Korea) containing protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). We used a solution of copper (II) sulfate and bicinchoninic acid (Sigma-Aldrich, St. Louis, MO, USA) to measure the protein concentrations of the extracts. Equal amounts of protein (20 μg) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to enhanced chemiluminescence nitrocellulose membranes (GE Healthcare, Little Chalfont, UK), and then blocked for 1 h with 5% skim milk in Tris-buffered saline containing 0.1% TWEEN® 20. The membranes were incubated overnight at 4°C with rabbit anti-LC3 (1 : 1,000; Abcam, Cambridge, MA, USA), rabbit anti-Beclin 1 (1 : 1,000; Novus Biologicals, Centennial, CO, USA), rabbit anti-Atg5 (1 : 1,000; Abcam), rabbit anti-p65 (1 : 1,000; Abcam), rabbit anti-phospho p65 (1 : 1,000; Abcam), rabbit anti-TNF-α (1 : 1,000; Abcam), rabbit anti-Nox2 (1 : 1,000; Abcam), rabbit anti-Nox4 (1 : 1,000; Abcam), or rabbit anti-Nrf2 (1 : 1,000; Abcam) antibodies. The primary antibodies were detected using horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse (1 : 1,000, Abcam) IgG secondary antibodies. We visualized the protein bands using LuminoGraph II (Atto, Tokyo, Japan). Densitometric analysis was performed using ImageJ version 1.8.0 (National Institutes of Health).

2.4. Statistical Analyses

We conducted a one-way ANOVA with Tukey’s post hoc tests to analyze the differences in body weight; blood glucose levels; TNF-α, Nox2, Nox4, Nrf2, LC3, Beclin 1, and Atg5 mRNA and protein expression; p65 mRNA expression; and phosphorylated p65 protein levels among the groups. Statistical analyses were performed using GraphPad Prism version 5.01 (GraphPad Software, San Diego, CA, USA). Significance was set at .

3. Results

3.1. Tetrahydrocurcumin Treatment Lowered TNF-α mRNA and Protein Expressions in the Skin of Obese Mice

As expected, after 12 weeks of treatment, the HFD group mice presented a significantly higher body weight and blood glucose level than the regular diet group mice. The HFD+T100 group presented a significantly lower body weight than the HFD-alone group mice (Figures 2(a) and 2(b)). Furthermore, TNF-α mRNA expression was significantly higher in the HFD group mice than in the regular diet group mice. However, the HFD+T100 group mice had significantly lower skin TNF-α mRNA expression than the HFD group mice (Figure 2(c)). TNF-α protein expression exhibited the same patterns as mRNA expression (Figures 2(d) and 2(e)).

3.2. THC Alleviated Oxidative Stress in the Skin of Obese Mice

Nox2 and Nox4 contribute to reactive oxygen species production [11], whereas Nrf2 is a component of cellular antioxidant pathways [18]. We measured Nox2, Nox4, and Nrf2 expressions to evaluate the changes in oxidative stress in the skin. The results of qRT-PCR showed that Nox2 and Nox4 mRNA levels were significantly higher, and the Nrf2 mRNA level was significantly lower in the skin of HFD-fed mice than in the skin of regular diet-fed mice (Figures 3(a)3(c)). THC treatment attenuated the HFD-induced increase in the Nox2 and Nox4 mRNA expressions (Figures 3(a) and 3(b)). In contrast, Nrf2 mRNA expression in the HFD+T100 mouse skin was higher than that in the HFD mouse skin (Figure 3(c)). The expression profiles of Nox2, Nox4, and Nrf2 proteins were similar to those of the mRNA (Figures 3(d)3(g)).

3.3. THC Suppressed the Induction of Autophagic Flux in the Skin of Obese Mice

To investigate the effects of obesity and THC on autophagy, we measured the expression of the autophagy-related factors LC3, Beclin 1, and Atg5. The mRNA expression of LC3, BECN1, and Atg5 in the skin of HFD-fed mice was significantly higher than that in the skin of regular diet-fed mice. However, THC treatment significantly inhibited the HFD-induced increases in LC3, BECN1, and Atg5 mRNA expressions (Figures 4(a)4(c)). The protein expression pattern was similar to the mRNA expression pattern in all three groups (Figures 4(d)4(g)).

3.4. NF-κB/p65 Signaling Pathway Mediates the Anti-Inflammatory and Antioxidant Effects of THC in the Skin of Obese Mice

The NF-κB/p65 signaling pathway plays a central role in innate and adaptive immune responses by inducing proinflammatory genes and regulating immune cells [19]. To determine the detailed mechanisms underlying the anti-inflammatory and antioxidant effects of THC, we evaluated its effect on the NF-κB/p65 expression. p65 mRNA expression and phosphorylated p65 protein levels in the skin of HFD-fed mice were significantly higher than those in the skin of regular-diet-fed mice. p65 mRNA expression and phosphorylated p65 protein levels were significantly lower in the skin of HFD+T100-fed mice than in the skin of HFD-fed mice (Figure 5).

4. Discussion

Our results supported that HFD-induced obesity affected inflammatory cytokines, oxidative stress, and autophagy markers in the skin. In terms of potential mechanisms, a recent in vivo study using an imiquimod-induced psoriatic dermatitis animal model showed that HFD exacerbates psoriatic dermatitis by increasing IL-17A-producing T cells in the skin [20]. Another study found that the typical high-fat, high-sugar western diet enhanced susceptibility to imiquimod-induced psoriatic dermatitis in mice [21]. Our research was consistent with these previous results and suggests that HFD induces skin inflammation with molecular changes in cytokine production and autophagy, although no obvious changes to skin morphology occurred.

The role of oxidative stress has been emphasized in obese patients with chronic inflammatory skin disease such as psoriasis [22]. The nuclear factor- (NF-) κB pathway is related to inflammatory responses through the regulation of the innate and adaptive arms of the immune system [23]. NF-κB, a redox-sensitive factor, is also associated with oxidative stress [24]. Notably, a vicious cycle has been reported between the NF-κB pathway and oxidative stress. Oxidative stress is important in the activation of the NF-κB pathway and inflammatory cytokines are induced following activation of this pathway, exacerbating the oxidative stress [25]. Of note, Carlsen et al. reported that NF-κB is activated in the whole body in obese mice fed a HFD [26]. Furthermore, obesity makes the skin more susceptible to UVB-induced oxidative stress and activation of the NF-κB signaling pathway in mice [27]. The present study showed that obesity induced the NF-κB activation as well as oxidative stress in the skin.

Previous studies using both human and mouse tissues demonstrated that obesity leads to the accumulation of autophagosomes in the liver and adipose tissues [28, 29]. Notably, we found in the present study that obesity induced skin autophagy. Autophagy may be a defense mechanism component to maintain cellular homeostasis under obesity-associated stress, compensating for obesity-associated endoplasmic reticulum stress [10]. Lipotoxic activation of protein kinase C induces autophagic flux in fibroblasts, protecting the cells from apoptosis [30]. Autophagy is closely associated with inflammatory skin diseases such as psoriasis [31]. Several studies provide a glimpse of possible mechanisms. For instance, autophagy inhibition increases cellular cholesterol levels during the IL-17A-mediated inflammatory response in keratinocytes [32]. In humans and mice, keratinocyte autophagy is positively correlated with psoriasis severity [31]. Moreover, impaired keratinocyte autophagy leads to psoriatic skin inflammation by activating aryl hydrocarbon receptor signaling [12].

Curcumin suppresses HFD-induced insulin resistance and obesity by decreasing liver lipogenesis and inhibiting adipocyte inflammatory pathways [33]. Additionally, curcumin ameliorates oxidative stress and Nrf2 signaling dysfunction in the muscles of HFD-fed mice [34]. However, curcumin has low bioavailability and poor absorption, limiting its therapeutic potential [35]. One way to overcome these limitations is to use THC, which has stronger antioxidant activity [17]. Recent studies have investigated the anti-inflammatory and antioxidant roles of THC, a major active metabolite of curcumin, against tumors and inflammatory diseases [36, 37]. The compound can protect against cisplatin-induced or FK506-related nephrotoxicity by regulating inflammation and apoptosis [38]. Here, we have reported the antioxidant and anti-inflammatory effects of THC on obesity-induced skin impairment. Interestingly, these effects were associated with modulation of skin autophagy.

This study had some limitations that should be addressed in future research. First, the relationship between obesity and inflammatory skin diseases should be confirmed with further studies using animal skin disease models (e.g., imiquimod-induced psoriasiform inflammation). Second, the clinical relevance of these obesity-related effects on human skin must be verified in human research. Third, we should clarify the actual anti-inflammatory mechanism of THC in the skin, specifically determining the main target cells via in vitro experiments.

5. Conclusions

In summary, we examined the effects of diet-induced obesity on skin inflammation and investigated the underlying mechanisms. We found that obesity-induced skin inflammation is associated with cutaneous oxidative stress, autophagy, and the NF-κB/p65 signaling pathway. Promisingly, THC ameliorated these effects. Thus, obesity management may be an effective method for promoting the recovery from skin inflammation, the latter of which can be addressed specifically through THC, a promising therapeutic. Using HFD skin disease models, future studies are needed to clarify whether there are common pathomechanisms between obesity and skin inflammation. Moreover, clinical trials are required to investigate the efficacy of THC for patients suffering not only from inflammatory skin diseases but also from obesity.

Data Availability

The datasets analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Acknowledgments

This work was supported by the National Research Foundation of Korea (NRF) of the Korean Government (MSIT) (grant numbers 2021R1F1A1059510, 2020M3E5D1A02030067), the Hallym University Research Fund (grant number HURF-2019-72), and the Soonchunhyang University Research Fund.

References

  1. P. G. Kopelman, “Obesity as a medical problem,” Nature, vol. 404, no. 6778, pp. 635–643, 2000. View at: Publisher Site | Google Scholar
  2. A. Chiricozzi, A. Raimondo, S. Lembo et al., “Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity,” Expert Review of Clinical Immunology, vol. 12, no. 12, pp. 1299–1308, 2016. View at: Publisher Site | Google Scholar
  3. A. Ibuki, T. Akase, T. Nagase et al., “Skin fragility in obese diabetic mice: possible involvement of elevated oxidative stress and upregulation of matrix metalloproteinases,” Experimental Dermatology, vol. 21, no. 3, pp. 178–183, 2012. View at: Publisher Site | Google Scholar
  4. G. L. Hidalgo, “Dermatological complications of obesity,” American Journal of Clinical Dermatology, vol. 3, no. 7, pp. 497–506, 2002. View at: Publisher Site | Google Scholar
  5. M. Nino, A. Franzese, R. N. Perrino, and N. Balato, “The effect of obesity on skin disease and epidermal permeability barrier status in children,” Pediatric Dermatology, vol. 29, no. 5, pp. 567–570, 2012. View at: Publisher Site | Google Scholar
  6. D. J. Klionsky and S. D. Emr, “Autophagy as a regulated pathway of cellular degradation,” Science, vol. 290, no. 5497, pp. 1717–1721, 2013. View at: Google Scholar
  7. A. Trocoli and M. Djavaheri-Mergny, “The complex interplay between autophagy and NF-κB signaling pathways in cancer cells,” American Journal of Cancer Research, vol. 1, no. 5, pp. 629–649, 2011. View at: Google Scholar
  8. D. Senft and Z. A. Ronai, “UPR, autophagy, and mitochondria crosstalk underlies the ER stress response,” Trends in Biochemical Sciences, vol. 40, no. 3, pp. 141–148, 2015. View at: Publisher Site | Google Scholar
  9. Y. M. Lim, H. Lim, K. Y. Hur et al., “Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes,” Nature Communications, vol. 5, no. 1, p. 4934, 2014. View at: Publisher Site | Google Scholar
  10. H. W. Park and J. H. Lee, “Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies,” Autophagy, vol. 10, no. 12, pp. 2385-2386, 2015. View at: Google Scholar
  11. J. Kaur and J. Debnath, “Autophagy at the crossroads of catabolism and anabolism,” Nature Reviews Molecular Cell Biology, vol. 16, no. 8, pp. 461–472, 2015. View at: Publisher Site | Google Scholar
  12. H. R. Kim, S. Y. Kang, H. O. Kim, C. W. Park, and B. Y. Chung, “Role of aryl hydrocarbon receptor activation and autophagy in psoriasis-related inflammation,” International Journal of Molecular Sciences, vol. 21, no. 6, p. 2195, 2020. View at: Publisher Site | Google Scholar
  13. E. Sivridis, A. Giatromanolaki, G. Karpathiou, A. Karpouzis, C. Kouskoukis, and M. I. Koukourakis, “LC3A-positive “stone-like” structures in cutaneous squamous cell carcinomas,” American Journal of Dermatopathology, vol. 33, no. 3, pp. 285–290, 2011. View at: Publisher Site | Google Scholar
  14. M. Songane, J. Kleinnijenhuis, M. G. Netea, and R. van Crevel, “The role of autophagy in host defence against _Mycobacterium tuberculosis_ infection,” Tuberculosis (Edinburgh, Scotland), vol. 92, no. 5, pp. 388–396, 2012. View at: Publisher Site | Google Scholar
  15. A. W. K. Yeung, M. Horbańczuk, N. T. Tzvetkov et al., “Curcumin: total-scale analysis of the scientific literature,” Molecules, vol. 24, no. 7, p. 1393, 2019. View at: Publisher Site | Google Scholar
  16. A. H. Rahmani, M. A. Alsahli, S. M. Aly, M. A. Khan, and Y. H. Aldebasi, “Role of curcumin in disease prevention and treatment,” Advanced Biomedical Research, vol. 7, no. 1, p. 38, 2018. View at: Publisher Site | Google Scholar
  17. L. Pari and P. Murugan, “Tetrahydrocurcumin: effect on chloroquine-mediated oxidative damage in rat kidney,” Basic & Clinical Pharmacology & Toxicology, vol. 99, no. 5, pp. 329–334, 2006. View at: Publisher Site | Google Scholar
  18. L. Bao, J. Li, D. Zha et al., “Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathways,” International Immunopharmacology, vol. 54, pp. 245–253, 2018. View at: Publisher Site | Google Scholar
  19. P. Tripathi and A. Aggarwal, “NF-kB transcription factor: a key player in the generation of immune response,” Current Science, vol. 90, no. 4, pp. 519–531, 2006. View at: Google Scholar
  20. S. Nakamizo, T. Honda, A. Adachi et al., “High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells,” Scientific Reports, vol. 7, no. 1, p. 14076, 2017. View at: Publisher Site | Google Scholar
  21. S. Yu, X. Wu, Y. Zhou et al., “A Western diet, but not a high-fat and low-sugar diet, predisposes mice to enhanced susceptibility to imiquimod-induced psoriasiform dermatitis,” Journal of Investigative Dermatology, vol. 139, no. 6, pp. 1404–1407, 2019. View at: Publisher Site | Google Scholar
  22. T. Padhi and Garima, “Metabolic syndrome and skin: psoriasis and beyond,” Indian Journal of Dermatology, vol. 58, no. 4, pp. 299–305, 2013. View at: Publisher Site | Google Scholar
  23. T. Liu, L. Zhang, D. Joo, and S. C. Sun, “NF-κB signaling in inflammation,” Signal Transduction and Targeted Therapy, vol. 2, article e17023, 2017. View at: Google Scholar
  24. M. J. Morgan and Z. Liu, “Crosstalk of reactive oxygen species and NF-κB signaling,” Cell Research, vol. 21, no. 1, pp. 103–115, 2011. View at: Publisher Site | Google Scholar
  25. K. Lingappan, “NF-κB in oxidative stress,” Current Opinion in Toxicology, vol. 7, pp. 81–86, 2018. View at: Publisher Site | Google Scholar
  26. H. Carlsen, F. Haugen, S. Zadelaar et al., “Diet-induced obesity increases NF-κB signaling in reporter mice,” Genes & Nutrition, vol. 4, no. 3, pp. 215–222, 2009. View at: Publisher Site | Google Scholar
  27. S. K. Katiyar and S. M. Meeran, “Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-κB signaling,” Free Radical Biology & Medicine, vol. 42, no. 2, pp. 299–310, 2007. View at: Publisher Site | Google Scholar
  28. S. Mei, H. M. Ni, S. Manley et al., “Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 2, pp. 487–498, 2011. View at: Publisher Site | Google Scholar
  29. C. E. Nuñez, V. S. Rodrigues, F. S. Gomes et al., “Defective regulation of adipose tissue autophagy in obesity,” International Journal of Obesity, vol. 37, no. 11, pp. 1473–1480, 2013. View at: Publisher Site | Google Scholar
  30. S. H. Tan, G. Shui, J. Zhou et al., “Induction of Autophagy by Palmitic Acid via Protein Kinase C-mediated Signaling Pathway Independent of mTOR (Mammalian Target of Rapamycin),” Journal of Biological Chemistry, vol. 287, no. 18, pp. 14364–14376. View at: Publisher Site | Google Scholar
  31. Z. Wang, X. Yin, W. Gan et al., “PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma,” Autophagy, vol. 21, pp. 1–19, 2020. View at: Publisher Site | Google Scholar
  32. P. Varshney and N. Saini, “PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis,” Biochimica et Biophysica Acta, Molecular Basis of Disease, vol. 1864, no. 5, pp. 1795–1803, 2018. View at: Publisher Site | Google Scholar
  33. W. Shao, Z. Yu, Y. Chiang et al., “Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes,” PLoS One, vol. 7, no. 1, article e28784, 2012. View at: Publisher Site | Google Scholar
  34. H. J. He, G. Y. Wang, Y. Gao, W. H. Ling, Z. W. Yu, and T. R. Jin, “Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice,” World Journal of Diabetes, vol. 3, no. 5, pp. 94–104, 2012. View at: Publisher Site | Google Scholar
  35. S. J. Stohs, C. Y. O. Chen, H. G. Preuss et al., “The fallacy of enzymatic hydrolysis for the determination of bioactive curcumin in plasma samples as an indication of bioavailability: a comparative study,” BMC Complementary and Alternative Medicine, vol. 19, no. 1, p. 293, 2019. View at: Publisher Site | Google Scholar
  36. Y. H. Tseng, S. S. Chiou, J. P. Weng, and P. C. Lin, “Curcumin and tetrahydrocurcumin induce cell death in Ara-C-resistant acute myeloid leukemia,” Phytotherapy Research, vol. 33, no. 4, pp. 1199–1207, 2019. View at: Publisher Site | Google Scholar
  37. B. L. Chen, Y. Q. Chen, B. H. Ma et al., “Tetrahydrocurcumin, a major metabolite of curcumin, ameliorates allergic airway inflammation by attenuating Th2 response and suppressing the IL-4Rα-Jak1-STAT6 and Jagged1/Jagged2 -Notch1/Notch2 pathways in asthmatic mice,” Clinical & Experimental Allergy, vol. 48, no. 11, pp. 1494–1508, 2018. View at: Publisher Site | Google Scholar
  38. C. S. Park, H. J. Jang, J. H. Lee, M. Y. Oh, and H. J. Kim, “Tetrahydrocurcumin ameliorates tacrolimus-induced nephrotoxicity via inhibiting apoptosis,” Transplantation Proceedings, vol. 50, no. 9, pp. 2854–2859, 2018. View at: Publisher Site | Google Scholar

Copyright © 2021 Jung Eun Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views427
Downloads695
Citations

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.